Literature DB >> 15781811

Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population.

A M Remes1, K Majamaa-Voltti, M Kärppä, J S Moilanen, S Uimonen, H Helander, H Rusanen, P I Salmela, M Sorri, I E Hassinen, K Majamaa.   

Abstract

BACKGROUND: Large-scale mitochondrial DNA (mtDNA) deletions are associated with clinical conditions such as Kearns-Sayre syndrome and chronic progressive external ophthalmoplegia in adults and Pearson syndrome in children. Reported case series have suggested that deletions are not uncommon in the population, but their prevalence has not been documented.
METHODS: The authors ascertained patients with clinical features associated with mtDNA deletions in a defined adult population in northern Finland. Buccal epithelial samples were requested from each patient fulfilling the selection criteria, and full-length mtDNA was amplified using the long PCR method. Deletion breakpoints were identified using sequencing. Patients with deletions were examined clinically.
RESULTS: The authors identified four patients with single large-scale mtDNA deletions. The prevalence of deletions was calculated to be 1.6/100,000 in the adult population in the province of Northern Ostrobothnia (0.0 to 3.2; 95% CI). Analysis of incident cases from a neighboring province revealed two patients with deletions and yielded a similar population frequency.
CONCLUSIONS: The frequency of large-scale mitochondrial DNA deletions is similar among populations, suggesting that there is a constant rate of new deletions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781811     DOI: 10.1212/01.WNL.0000154518.31302.ED

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Mitochondrial DNA Depletion and Deletions in Paediatric Patients with Neuromuscular Diseases: Novel Phenotypes.

Authors:  Tuomas Komulainen; Milla-Riikka Hautakangas; Reetta Hinttala; Salla Pakanen; Vesa Vähäsarja; Petri Lehenkari; Päivi Olsen; Päivi Vieira; Outi Saarenpää-Heikkilä; Johanna Palmio; Hannu Tuominen; Pietari Kinnunen; Kari Majamaa; Heikki Rantala; Johanna Uusimaa
Journal:  JIMD Rep       Date:  2015-05-05

2.  POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.

Authors:  Tuomas Komulainen; Reetta Hinttala; Mikko Kärppä; Leila Pajunen; Saara Finnilä; Hannu Tuominen; Heikki Rantala; Ilmo Hassinen; Kari Majamaa; Johanna Uusimaa
Journal:  BMC Neurol       Date:  2010-05-03       Impact factor: 2.474

3.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

4.  A novel MTTT mutation m.15933G > A revealed in analysis of mitochondrial DNA in patients with suspected mitochondrial disease.

Authors:  Heidi K Soini; Antti Väisänen; Mikko Kärppä; Reetta Hinttala; Laura Kytövuori; Jukka S Moilanen; Johanna Uusimaa; Kari Majamaa
Journal:  BMC Med Genet       Date:  2017-02-10       Impact factor: 2.103

5.  A rare case of Kearns-Sayre syndrome in a 17-year-old Venezuelan male with bilateral ptosis as the initial presentation.

Authors:  Mayela Leal; Chetan Dhoble; Julie Lee; Deinymar Lopez; Laura Simonne Menéndez
Journal:  Oxf Med Case Reports       Date:  2016-03-03

6.  Anesthetic management of a parturient with Kearns-Sayre syndrome, dual-chamber and VVI implantable defibrillator pacemaker/defibrillator, and preeclampsia for cesarean delivery: A case report and review of the literature.

Authors:  Abdulmohsen Al Ghamdi
Journal:  Saudi J Anaesth       Date:  2018 Jan-Mar

7.  Retinal Manifestations of Mitochondrial Oxidative Phosphorylation Disorders.

Authors:  Jin Kyun Oh; Jose Ronaldo Lima de Carvalho; Yan Nuzbrokh; Joseph Ryu; Teja Chemudupati; Vinit B Mahajan; Janet R Sparrow; Stephen H Tsang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.